Furthermore, in triple-negative breast cancer (TNBC) and basal-like breast cancer (n = 243) cases, ZBTB16 expression was lower than that in non-basal-like breast cancer and non-TNBC groups (n = 3539) in bc-GenExMiner (Fig. 1c). Here, ZBTB16 is linked to triple-negative breast carcinoma.